Basic Information
Basic information for LINC00917-217-43aa
Peptide Name LINC00917-217-43aa
Genome Position chr16:86332252-86332380[-]
Species Human
Peptide Sequence MDRRREKGPVLAGDAIQDICILIPGTWDSTRCHGKEGLRWQVE
Peptide Length 43
Unique No (LINC00917-201-43aa,LINC00917-202-43aa,LINC00917-204-43aa,LINC00917-206-43aa,LINC00917-207-43aa,LINC00917-208-43aa,LINC00917-209-43aa,LINC00917-210-43aa,LINC00917-211-43aa,LINC00917-212-43aa,LINC00917-213-43aa,LINC00917-214-43aa,LINC00917-215-43aa)
Grand Average of Hydropathicity -0.6023
Relative Molecular Mass 5664.29
Experimental Evidences no
lncRNA ID/Name ENSG00000168367;LINC00917
Transcript ID/Name ENST00000670118;LINC00917-217
Transcript Length 2513
Coding Ability 0.3645
DNA Sequence Corresponding to Peptide ATGGACAGGAGGAGGGAAAAGGGACCTGTGCTAGCAGGTGATGCCATCCAAGACATCTGCATCCTAATCCCTGGAACCTGGGATTCCACTAGGTGCCATGGCAAAGAGGGATTAAGGTGGCAGGTGGAG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :